First in human study to evaluate AZD9793 in participants with advanced or metastatic solid tumours

Trial Identifier:	D7040C00001
Sponsor:	AstraZeneca
Start Date:	March 2025
Primary Completion Date:	February 2028
Study Completion Date:	July 2028
Condition:	Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
HK	Shatin, HK, 00000
JP	Kashiwa, JP, 277-8577
KR	Seoul, KR, 5505
US, MO	Saint Louis, MO, US, 63110
US, TX	Houston, TX, US, 77030

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.